Does Dodge & Cox own GSK1 stock?

As of its Q2 2022 13F, Dodge & Cox held 74,242,722 shares of GSK1 (Glaxosmithkline), worth $3.2B.

How many shares of GSK1 does Dodge & Cox own?

As of its Q2 2022 13F, Dodge & Cox held 74,242,722 shares of GSK1 (Glaxosmithkline).

As of its Q2 2022 13F, Dodge & Cox's GSK1 position was worth $3.2B.

Dodge & Cox already held GSK1 in its Q4 2018 13F, the earliest on record, and listed it in 15 quarterly 13F filings.

Position history for DODGE & COX's holdings in GLAXOSMITHKLINE PLC-SPON ADR

Final Value

Final Shares

Total Value Change

-$1.8B

Total Shares Change

-48M

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2022-Q3 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2022-Q2	Decreased	74.2M	-13.4%	$3.2B	2.2%	—	0
2022-Q1	Decreased	85.8M	-3.1%	$3.7B	2.3%	—	0
2021-Q4	Increased	88.5M	+0.6%	$3.9B	2.4%	—	55
2021-Q3	Decreased	88M	-0.2%	$3.4B	2.2%	—	0
2021-Q2	Increased	88.2M	+0.3%	$3.5B	2.3%	—	55
2021-Q1	Increased	87.9M	+39.7%	$3.1B	2.2%	—	72
2020-Q4	Increased	62.9M	+39.9%	$2.3B	1.8%	—	67
2020-Q3	Increased	45M	+8.4%	$1.7B	1.6%	—	55
2020-Q2	Decreased	41.5M	-5.7%	$1.7B	1.6%	—	0
2020-Q1	Decreased	44M	-5.1%	$1.7B	1.8%	—	0
2019-Q4	Decreased	46.4M	-4.0%	$2.2B	1.7%	—	0
2019-Q3	Increased	48.3M	+0.2%	$2.1B	1.7%	—	50
2019-Q2	Increased	48.2M	+0.3%	$1.9B	1.6%	—	50
2019-Q1	Increased	48.1M	+0.2%	$2B	1.6%	—	50
2018-Q4	First report	48M	-	$1.8B	1.7%	—	0